Media Highlights and Announcements
November 04, 2021
Cardiac imaging start-up Artrya raising $40m through an IPO
In this article, the Financial Review shares some information on our accomplishments, IPO and overall progress towards our goals.
After closing our initial public offering (IPO), the Motley Fool shares details on Artrya’s AI technology and how it could disrupt the detection of coronary artery disease for years to come.
October 26, 2021
From the heart: Pandemic no barrier for medtech’s ASX listing
Amid a biotech boom, see how Artrya, an aussie medtech company, is pioneering the detection and assessment of the underlying cause of heart attack.
October 25, 2021
Artrya MD John Barrington on next month’s listing and commercialising AI health tech
Artrya’s co-founder and Managing Director, John Barrington AM, recently took part in a Q&A with Stockhead.
Artrya has lodged a prospectus with ASIC with a view to list on the Australian Stock Exchange.
September 23, 2021
The Technologies Making Moves in Medical Imaging AI
We’re proud to be acknowledged in Signify Research’s Product Developments & Technology Trends report.
Business NewsJune 21, 2021
Researchers Eye Health Benefit From AI
Several exciting AI innovations are emerging from WA, and the world is watching.
University of Western AustraliaMay 31, 2021
Artificial Intelligence To Predict Heart Disease
AI to predict heart disease.
Australian Financial ReviewMay 25, 2021
AI-powered imaging software has raised $15 million from institutional investors
Artrya raises $15m for AI software to transform cardiac imaging.
March 31, 2021
Artrya Marches To Its Own Beat – MTPConnect Podcast
MTPConnect talks to Artrya. In this week’s episode, we chat with WA-based digital health company Artrya’s Co-Founders.